Arcadia Biosciences Inc. (RKDA)
NASDAQ: RKDA
· Real-Time Price · USD
3.35
-0.16 (-4.56%)
At close: Sep 26, 2025, 10:57 AM
-4.56% (1D)
| Bid | 3.3 |
| Market Cap | 4.57M |
| Revenue (ttm) | 5.41M |
| Net Income (ttm) | -7.54M |
| EPS (ttm) | -5.19 |
| PE Ratio (ttm) | -0.64 |
| Forward PE | -1.49 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.35 |
| Volume | 2,567 |
| Avg. Volume (20D) | 10,395 |
| Open | 3.42 |
| Previous Close | 3.51 |
| Day's Range | 3.18 - 3.42 |
| 52-Week Range | 2.53 - 10.31 |
| Beta | 0.57 |
| Ex-Dividend Date | n/a |
About RKDA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RKDA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RKDA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsArcadia Biosciences Inc. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
9 months ago
+101.85%
Arcadia Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription
10 months ago
-7.88%
Arcadia Biosciences shares are trading lower. The stock may be moving on continued weakness following a Q3 earnings miss reported on Tuesday.
4 months ago · seekingalpha.com
Arcadia Biosciences, Inc. (RKDA) Q1 2025 Earnings Call TranscriptArcadia Biosciences, Inc. (NASDAQ:RKDA ) Q1 2025 Earnings Conference Call May 8, 2025 2:00 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President and Chief Execut...